Metten Somers

Metten Somers is a psychiatrist and Medical Director of the Affective and Psychotic Disorders Unit of the Department of Psychiatry at the UMC Utrecht. He was involved in the OPTiMISE trial as project manager and obtained his PhD on the relationship between language lateralization and left-handedness using psychiatric genetic and neuroimaging techniques. He holds an executive MBA degree from the Rotterdam School of Management, Erasmus University. His current clinical and research work focuses on treatment resistant mood and psychotic disorders, with a special interest in electroconvulsive therapy.His interest in a role for psychedelics in psychiatry resulted in his involvement as site-PI in the trial ‘Psilocybin in Treatment Resistant Depression’, the first international large scale multicenter randomized clinical trial investigating the effectiveness and safety of psilocybin in depression.